Stryker Corporation (SYK) Position Cut by Campbell & CO Investment Adviser LLC
Campbell & CO Investment Adviser LLC lessened its holdings in shares of Stryker Corporation (NYSE:SYK) by 36.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,720 shares of the medical technology company’s stock after selling 1,559 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Stryker were worth $386,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in SYK. Acrospire Investment Management LLC bought a new stake in Stryker in the 2nd quarter worth approximately $111,000. Motco boosted its holdings in shares of Stryker by 50.7% in the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 278 shares during the period. Bruderman Asset Management LLC purchased a new position in shares of Stryker in the 2nd quarter worth approximately $150,000. James Investment Research Inc. purchased a new position in shares of Stryker in the 2nd quarter worth approximately $155,000. Finally, BB&T Investment Services Inc. purchased a new position in shares of Stryker in the 2nd quarter worth approximately $178,000. 74.97% of the stock is currently owned by institutional investors and hedge funds.
In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the sale, the insider now directly owns 83,207 shares in the company, valued at approximately $12,925,375.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 7.40% of the stock is currently owned by corporate insiders.
A number of equities analysts have recently commented on the company. Cowen set a $166.00 target price on Stryker and gave the stock a “buy” rating in a report on Sunday, October 29th. Needham & Company LLC reiterated a “hold” rating on shares of Stryker in a report on Friday, November 3rd. SunTrust Banks reiterated a “buy” rating and issued a $161.00 target price on shares of Stryker in a report on Friday, November 17th. Oppenheimer set a $156.00 target price on Stryker and gave the stock a “hold” rating in a report on Monday, October 30th. Finally, Robert W. Baird upgraded Stryker from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from $161.00 to $173.00 in a report on Thursday, November 16th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $152.10.
Stryker Corporation (NYSE SYK) traded up $1.90 on Thursday, reaching $156.00. The company had a trading volume of 737,807 shares, compared to its average volume of 1,171,917. Stryker Corporation has a one year low of $110.91 and a one year high of $160.62. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. The stock has a market cap of $58,298.73, a PE ratio of 24.69, a P/E/G ratio of 2.45 and a beta of 0.79.
Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.50 by $0.02. Stryker had a return on equity of 24.11% and a net margin of 14.67%. The company had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. During the same quarter in the previous year, the business earned $1.39 EPS. Stryker’s revenue was up 6.1% compared to the same quarter last year. sell-side analysts anticipate that Stryker Corporation will post 6.47 EPS for the current fiscal year.
WARNING: “Stryker Corporation (SYK) Position Cut by Campbell & CO Investment Adviser LLC” was posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/11/30/stryker-corporation-syk-position-cut-by-campbell-co-investment-adviser-llc.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.